Oak Grove Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.98M | Buy |
82,960
+700
| +0.9% | +$80.8K | 0.85% | 24 |
|
|
2025
Q4 | $8.66M | Sell |
82,260
-8,555
| -9% | -$803K | 1.03% | 25 |
|
|
2025
Q3 | $7.62M | Sell |
90,815
-21,515
| -19% | -$1.77M | 1.08% | 24 |
|
|
2025
Q2 | $8.89M | Sell |
112,330
-66,880
| -37% | -$5.32M | 1.46% | 19 |
|
|
2025
Q1 | $16.1M | Buy |
179,210
+27,700
| +18% | +$2.59M | 3.35% | 9 |
|
|
2024
Q4 | $15.1M | Buy |
151,510
+67,272
| +80% | +$6.94M | 2.25% | 15 |
|
|
2024
Q3 | $9.57M | Buy |
84,238
+33,977
| +68% | +$4.04M | 1.57% | 15 |
|
|
2024
Q2 | $6.22M | Buy |
50,261
+1,944
| +4% | +$250K | 1.13% | 18 |
|
|
2024
Q1 | $6.38M | Buy |
48,317
+964
| +2% | +$119K | 1.29% | 18 |
|
|
2023
Q4 | $5.16M | Buy |
47,353
+27,193
| +135% | +$2.82M | 1.37% | 20 |
|
|
2023
Q3 | $2.08M | Buy |
20,160
+2,660
| +15% | +$287K | 0.72% | 26 |
|
|
2023
Q2 | $2.02M | Buy |
17,500
+3,500
| +25% | +$397K | 0.69% | 26 |
|
|
2023
Q1 | $1.49M | Buy |
14,000
+5,100
| +57% | +$551K | 0.61% | 25 |
|
|
2022
Q4 | $987K | Hold |
8,900
| – | – | 0.5% | 28 |
|
|
2022
Q3 | $766K | Hold |
8,900
| – | – | 0.26% | 40 |
|
|
2022
Q2 | $811K | Sell |
8,900
-500
| -5% | -$44.3K | 0.26% | 41 |
|
|
2022
Q1 | $771K | Hold |
9,400
| – | – | 0.16% | 52 |
|
|
2021
Q4 | $720K | Sell |
9,400
-1,000
| -10% | -$79.6K | 0.13% | 63 |
|
|
2021
Q3 | $781K | Hold |
10,400
| – | – | 0.17% | 61 |
|
|
2021
Q2 | $809K | Sell |
10,400
-499
| -5% | -$37.1K | 0.18% | 61 |
|
|
2021
Q1 | $802K | Sell |
10,899
-960
| -8% | -$70.8K | 0.22% | 57 |
|
|
2020
Q4 | $926K | Sell |
11,859
-403
| -3% | -$30.8K | 0.3% | 47 |
|
|
2020
Q3 | $971K | Sell |
12,262
-5,030
| -29% | -$394K | 0.46% | 37 |
|
|
2020
Q2 | $1.28M | Buy |
17,292
+7,746
| +81% | +$583K | 0.77% | 28 |
|
|
2020
Q1 | $701K | Sell |
9,546
-26,829
| -74% | -$2.11M | 0.45% | 41 |
|
|
2019
Q4 | $3.16M | Buy |
36,375
+29,934
| +465% | +$2.46M | 1.23% | 29 |
|
|
2019
Q3 | $517K | Buy |
6,441
+353
| +6% | +$28.3K | 0.22% | 53 |
|
|
2019
Q2 | $487K | Sell |
6,088
-209
| -3% | -$16K | 0.26% | 51 |
|
|
2019
Q1 | $500K | Hold |
6,297
| – | – | 0.32% | 50 |
|
|
2018
Q4 | $459K | Hold |
6,297
| – | – | 0.41% | 40 |
|
|
2018
Q3 | $426K | Sell |
6,297
-210
| -3% | -$13.4K | 0.37% | 39 |
|
|
2018
Q2 | $377K | Hold |
6,507
| – | – | 0.38% | 36 |
|
|
2018
Q1 | $338K | Sell |
6,507
-1,886
| -22% | -$102K | 0.37% | 37 |
|
|
2017
Q4 | $451K | Buy |
+8,393
| New | +$465K | 0.47% | 41 |
|
Other funds holding MRK
VCM
VPM
Oak Grove Capital's MRK Position: Q1 2026 in Review
Oak Grove Capital increased its Merck (MRK) stake by 0.85% in Q1 2026, buying an estimated $80.8K and bringing the position to 82,960 shares worth $9.98M. The position accounts for 0.85% of the portfolio, ranked #24.
Oak Grove Capital first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $16.1M in Q1 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Oak Grove Capital held 82,960 shares of Merck worth $9.98M as of Q1 2026.
- Oak Grove Capital bought 700 Merck shares in Q1 2026, an estimated $80.8K.
- Merck made up 0.85% of Oak Grove Capital's portfolio in Q1 2026, its #24 holding.
- Oak Grove Capital first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- Oak Grove Capital's Merck position peaked at $16.1M in Q1 2025.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Oak Grove Capital's 13F filing for Q1 2026, filed 13 May 2026.